A novel combination treatment with apremilast and tumor necrosis factor inhibitor for a patient with refractory intestinal Behcet's disease. (2nd January 2022)

Record Type:: Journal Article
Title:: A novel combination treatment with apremilast and tumor necrosis factor inhibitor for a patient with refractory intestinal Behcet's disease. (2nd January 2022)
Main Title:: A novel combination treatment with apremilast and tumor necrosis factor inhibitor for a patient with refractory intestinal Behcet's disease
Authors:: Fukui, S
Kawaai, S
Tamaki, H
Fukuda, K
Okada, M
Abstract:
Is Part Of:: Scandinavian journal of rheumatology. Volume 51:Number 1(2022)
Journal:: Scandinavian journal of rheumatology
Issue:: Volume 51:Number 1(2022)
Issue Display:: Volume 51, Issue 1 (2022)
Year:: 2022
Volume:: 51
Issue:: 1
Issue Sort Value:: 2022-0051-0001-0000
Page Start:: 81
Page End:: 82
Publication Date:: 2022-01-02
Subjects:: Rheumatology -- Periodicals
Arthritis
Rheumatic Diseases
616.72005
Journal URLs:: http://informahealthcare.com/loi/rhe ↗
http://informahealthcare.com ↗
DOI:: 10.1080/03009742.2021.1929458 ↗
Languages:: English
ISSNs:: 0300-9742
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 8087.546000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 20311.xml